Jake Jorgovan

SEPTEMBER 22, 2023

These firms conduct market research, create bespoke compensation strategies, and offer governance advice. With a commitment to the highest ethical standards, Meridian offers a suite of comprehensive governance services designed to navigate challenging topics shaping today's corporate board agendas.

Life science 130

Life science Government Value creation Insurance 130

Jake Jorgovan

NOVEMBER 29, 2023

NGT BioPharma Consultants : A consultancy firm specializing in drug development and advanced technologies, offering comprehensive support from late discovery to life cycle management for both small molecules and biologics. Broad expertise in business and technical domains. Known for natural process improvement.

Biopharmaceuticals 130

Biopharmaceuticals Biopharma Biotech Life science 130

Jake Jorgovan

JANUARY 17, 2024

You improve sustainability and corporate responsibility, leveraging their expertise in integrating environmental and social governance (ESG) factors into your projects. This approach increases project value and optimizes value creation for clients and stakeholders.

Energy 130

Energy Mergers and acquisition activities Retail Engineering 130

Jake Jorgovan

FEBRUARY 1, 2024

A Deep Dive into each Life Science Consultant & Consulting Firm 1. BCG's leadership development consulting is operational and linked to value creation, emphasizing the development of a few critical capabilities that can change an organization's performance trajectory.

Partnering capability and readiness 130

Partnering capability and readiness Life science Government Value creation 130

Jake Jorgovan

DECEMBER 8, 2023

That’s how BarkerGilmore delivers long-term value and exceptional return on investment. These experts facilitate your company’s growth, value creation, and long-term success through exceptional leadership. You’ll like working with ASG Legal if you value a consultative approach.

Legal 130

Legal Law firms Mergers and acquisition activities Energy 130

LaVoie Health Science Blog

JULY 1, 2020

Sharp gains and losses in share prices, together with significant changes in share ownership mean that few companies, particularly those in the life science sector, are immune from the potential disruptions of shareholder activism. The COVID-19 pandemic has led to unprecedented volatility in equity markets.

Life science 52

Life science Biotech Biopharma Value creation 52

TIM Review

OCTOBER 30, 2020

The “business model” concept has indeed been utilized to comprehensively understand how companies do business and perform processes of value creation, capture, and delivery (Schneider & Spieth, 2013; Foss & Saebi, 2017). Health Care : Equipment and services, pharmaceuticals, biotechnology, life science.

Energy 52

Energy Value creation Utilities Banking 52